EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target

Li Fu, Zheng Liu, Yang Liu

International Immunopharmacology · 2023-03 · 116 · 109799

DOI: 10.1016/j.intimp.2023.109799 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-03. Verfasst von Li Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Ch…. Hauptthemen laut MEDLINE: Fibrinogen, Inflammation. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrinogen-like protein 2 (FGL2), a member of the fibrinogen family, exists as a membrane-bound protein with immune-associated coagulation activity and a soluble form possessing immunosuppressive functions. The immunomodulatory role of FGL2 is evident in fibrin deposition-associated inflammatory diseases and cancer, suggesting that FGL2 expression could be exploited as a disease biomarker and a therapeutic target. Recently, in vitro studies and knockout and transgenic animal FGL2 models have been used by us and others to reveal the involvement of FGL2 in the pathogenesis of various inflammatory diseases. This review summarizes our current knowledge of the immunomodulatory role of FGL2 in inflammatory diseases and examines the role of FGL2 as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinogenInflammationAnimalsHumans

Stichwörter der Autor:innen

FGL2Immunomodulatory roleInflammatory diseasesTherapeutic target

Substanzen

FibrinogenFGL2 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Allergy and Clinical Immunology, Tongji Hospital, To…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Fu, L., Liu, Z., & Liu, Y. (2023). Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target. International Immunopharmacology, 116, 109799. https://doi.org/10.1016/j.intimp.2023.109799

Vancouver

Fu L, Liu Z, Liu Y. Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target. International Immunopharmacology. 2023;116:109799. doi:10.1016/j.intimp.2023.109799

BibTeX
@article{Fu2023,
  author = {Fu, Li and Liu, Zheng and Liu, Yang},
  title = {Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {116},
  pages = {109799},
  doi = {10.1016/j.intimp.2023.109799}
}
Kostenlos starten →